Home > US regulators have "full confidence" in J&J Covid vaccine benefits

News
US regulators have "full confidence" in J&J Covid vaccine benefits

Description

US health regulators "have full confidence" that the Johnson & Johnson vaccine's "known and potential benefits outweigh its known and potential risks in individuals 18 years of age and older," says Janet Woodcock, head of the Food and Drug Administration, in a joint virtual press conference with the with the Centers for Disease Control and Prevention (CDC). Both agencies say Johnson & Johnson Covid vaccinations can restart, after the shots' rollout was paused due to worries over blood clotting.

Added on the 24/04/2021 13:48:29 - Copyright : AFP EN

To customise your video :

Or Create an account

More videos on the subject

  • COVID-19: Regulators Announce Allergy Warning for Pfizer Vaccine (1)

    15ea53a0-d69b-4ae8-bb8d-0db307743e0e

    01/10/2021 - Wochit
  • Cuba's Covid-19 vaccine approved by regulators in Havana

    Havana, Cuba Jul 9 (EFE) (camera Felipe Borrego) .- Latin America has its first indigenous vaccine for covid-19: the Cuban formulation Abdala, with an efficacy of 92.2% in clinical trials.

    10/07/2021 - EFE Inglés
  • EU regulators begin first rolling review of Chinese-made Covid-19 vaccine

    The Hague, May 4 (EFE/EPA).- (Camera: EFE/EPA)The European Medicines Agency on Tuesday began a rolling review of the first vaccine submitted for EU market authorization by a Chinese company. EFE/EPA ARCHIVE FOOTAGE.

    04/05/2021 - EFE Inglés
  • EU agency says J&J Covid-19 vaccine's benefits outweigh the risks

    Europe's medicines regulator says that blood clots should be listed as a very rare side effect of Johnson & Johnson's coronavirus vaccine, but that the benefits of the shot still outweigh the risks. SOUNDBITE

    20/04/2021 - AFPTV - First images
  • Unnecessary panic leads to lack of confidence in AstraZeneca's Covid-19 vaccine, researcher says

    London, March 19 (EFE), (Camera: Pilar Tomás).- The suspension of vaccination with AstraZeneca in a dozen European countries after registering several cases of thrombosis and embolisms contributed to an "unnecessary panic that can have a great negative impact on the vaccine confidence", warns Salvador Macip, a researcher at the University of Leicester. FOOTAGE OF LONDON.SOUNDBITES OF SALVADOR MACIP, RESEARCHER AT THE UNIVERSITY OF LEICESTER: "Covid-19 vaccination campaign in Europe is going bad, much more slowly than expected. And the problem is that the number of those vaccinated will determine the level of restrictions, the level of normalcy that each country has. Europe will be slower than the countries which are going well, such as Israel, UK or the US.""How is it going to develop? It is difficult to know but what we know is that we will reach the solution to pandemic through vaccination."

    19/03/2021 - EFE Inglés
  • Covid-19 : transfert exceptionnel de huit patients en réanimation de Tahiti vers Paris

    Le transfert de ces patients vers la métropole doit permettre d'alléger la pression sur les services de réanimation en Polynésie, actuellement l'un des territoires français les plus durement touchés par l'épidémie de Covid-19.

    19/09/2021 - Euronews FR

More videosNews

Watch video of  - DemainEntreprendre - épisode 12 - Label : Economie wallonne -
News

DemainEntreprendre - épisode 12

29/04/2021 12:55:32